Short-term Variations in Bodily Pain and Related Baseline Characteristics in Fibromyalgia Patients Undergoing Paraprobiotic Supplementation: A Retrospective Observational Analysis - Scorecard - MDSpire
Advertisement
Short-term Variations in Bodily Pain and Related Baseline Characteristics in Fibromyalgia Patients Undergoing Paraprobiotic Supplementation: A Retrospective Observational Analysis
Clinical Scorecard: Short-term Variations in Bodily Pain and Related Baseline Characteristics in Fibromyalgia Patients Undergoing Paraprobiotic Supplementation: A Retrospective Observational Analysis
At a Glance
Category
Detail
Condition
Fibromyalgia
Key Mechanisms
Paraprobiotic supplementation may influence bodily pain through non-viable microbial components.
Target Population
Women diagnosed with fibromyalgia.
Care Setting
Rheumatology Department, Hospital General Universitario de Ciudad Real, Spain.
Key Highlights
Bodily pain scores improved significantly at 2 months compared to baseline.
Dyslipidemia was associated with lower bodily pain scores.
The study utilized a retrospective observational design with 86 participants.
Guideline-Based Recommendations
Diagnosis
Fibromyalgia diagnosis based on clinical assessment and standardized questionnaires.
Management
Consider paraprobiotic supplementation as part of symptom management in fibromyalgia.
Monitoring & Follow-up
Regular assessment of bodily pain using the SF-36 questionnaire.
Risks
Caution in interpreting findings due to the observational design and lack of a control group.
Patient & Prescribing Data
86 women with fibromyalgia receiving paraprobiotic supplementation.
Short-term improvements in bodily pain observed over a 2-month follow-up.
Clinical Best Practices
Monitor baseline characteristics such as dyslipidemia and smoking status for better management of fibromyalgia.
Utilize validated tools like the SF-36 for assessing health-related quality of life.
